The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Daniel Pryor Biography and Net Worth

EVP of Enovis

Daniel Pryor has more than 20 years of mergers and acquisitions, strategy, and investment experience in the medical technology, life sciences, and industrial sectors. Prior to joining Enovis in 2011, Mr. Pryor was a partner and managing director with The Carlyle Group‚ where he focused on industrial leveraged buyouts. Before working at Carlyle‚ he spent 11 years at Danaher Corporation in various operating, mergers and acquisitions, and strategy roles of increasing responsibility, most recently as Vice President of Strategic Development. Mr. Pryor earned a Bachelor of Arts in economics from Williams College and an MBA from Harvard Business School.

What is Daniel A. Pryor's net worth?: The estimated net worth of Daniel A. Pryor is at least $5.02 million as of March 6th, 2023. Mr. Pryor owns 108,291 shares of Enovis stock worth more than $5,022,537 as of November 17th. This net worth approximation does not reflect any other investments that Mr. Pryor may own. Additionally, Mr. Pryor receives a salary of $1,290,000.00 as EVP at Enovis. Learn More about Daniel A. Pryor's net worth.
How old is Daniel A. Pryor?: Mr. Pryor is currently 56 years old. There are 7 older executives and no younger executives at Enovis. The oldest executive at Enovis is Ms. Patricia A. Lang, Senior VP & Chief Human Resources Officer, who is 65 years old. Learn More on Daniel A. Pryor's age.
What is Daniel A. Pryor's salary?: As the EVP of Enovis Co., Mr. Pryor earns $1,290,000.00 per year. There are 2 executives that earn more than Mr. Pryor. The highest earning executive at Enovis is Mr. Matthew L. Trerotola, CEO & Chairman, who commands a salary of $3,350,000.00 per year. Learn More on Daniel A. Pryor's salary.
How do I contact Daniel A. Pryor?: The corporate mailing address for Mr. Pryor and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Daniel A. Pryor's contact information.
Has Daniel A. Pryor been buying or selling shares of Enovis?: Daniel A. Pryor has not been actively trading shares of Enovis during the past quarter. Most recently, Daniel A. Pryor sold 1,898 shares of the business's stock in a transaction on Monday, March 6th. The shares were sold at an average price of $57.69, for a transaction totalling $109,495.62. Following the completion of the sale, the executive vice president now directly owns 108,291 shares of the company's stock, valued at $6,247,307.79. Learn More on Daniel A. Pryor's trading history.
Who are Enovis' active insiders?: Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.

Daniel A. Pryor Insider Trading History at Enovis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2023	Sell	1,898	$57.69	$109,495.62	108,291
2/27/2023	Sell	5,716	$56.08	$320,553.28	78,137
2/23/2023	Sell	1,113	$54.61	$60,780.93	73,512
2/21/2023	Sell	1,106	$62.11	$68,693.66	74,625
11/15/2022	Sell	67,421	$54.58	$3,679,838.18	75,731

Daniel A. Pryor Buying and Selling Activity at Enovis

Enovis Company Overview

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $46.38

$45.31

$46.61

50 Day Range

MA: $42.44

$38.72

$47.86

2 Week Range

Now: $46.38

$38.27

$65.03

Volume

467,649 shs

Average Volume

765,955 shs

Market Capitalization

$2.59 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Financial Prophecy

From Porter & Company | Ad